---
title: "SHL TeleMedicine (SHLT.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/SHLT.US.md"
symbol: "SHLT.US"
name: "SHL TeleMedicine"
industry: "Health Care Services"
---

# SHL TeleMedicine (SHLT.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |

## Company Profile

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-21T04:30:15.000Z

**Overall: C (0.59)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 66 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.04% |  |
| Net Profit YoY | -281.36% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 55.94M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -12.30% | D |
| Profit Margin | -15.80% | D |
| Gross Margin | 46.99% | B |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -2.04% | D |
| Net Profit YoY | -281.36% | E |
| Total Assets YoY | -14.17% | E |
| Net Assets YoY | -11.76% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -632.79% | E |
| OCF YoY | -2.04% | D |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.50 | C |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 31.68% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - SHL TeleMedicine",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-12.30%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-15.80%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "46.99%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-2.04%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-281.36%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-14.17%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-11.76%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-632.79%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-2.04%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.50",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "31.68%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Cigna (US.CI) | B | B | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (US.BTSGU) | C | A | A | D | A | B |
| 03 | Labcorp (US.LH) | B | C | B | C | B | B |
| 04 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B |
| 05 | BrightSpring Health Services (US.BTSG) | C | A | A | D | A | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -3.86 | 51/79 | - | - | - |
| PB | 0.51 | 6/79 | 0.51 | 0.51 | 0.51 |
| PS (TTM) | 0.61 | 27/79 | 0.61 | 0.61 | 0.61 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.05 |
| Highest Target | 11.00 |
| Lowest Target | 11.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/SHLT.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/SHLT.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/SHLT.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.